Heat Biologics's activity chart (see below) currently has 9 price targets and 11 ratings on display.
Analysts' price targets on this stock were met 33.33% of the time, taking 300.67 days on average.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 18-Mar-2022. First documented stock forecast 09-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Dec-2020
$8
$10
4 years 8 months 4 days ago
(18-Mar-2022)
0/4 (0%)
$5.37 (204.18%)
Buy Since 09-Jul-2018
$20
4 years 8 months 7 days ago
(15-Mar-2022)
1/2 (50%)
$13.27 (197.18%)
107
Buy Since 06-Mar-2020
$22
5 years 10 months ago
(22-Jan-2021)
1/2 (50%)
$15.11 (219.30%)
795
What is HTBX (Heat Biologics) average time for price targets to be met?
Which analyst most recently updated their price target on HTBX (Heat Biologics)?
Which analyst has the lowest performance score on HTBX (Heat Biologics) with a proven track record?
Which analyst has the most public recommendations on HTBX (Heat Biologics)?
Which analyst is the currently most bullish on HTBX (Heat Biologics)?
Which analyst is the currently most reserved on HTBX (Heat Biologics)?